Prof. Dr. Yendry Ventura is the Chief Executive Officer of ADSCC, the first fully integrated medical and research institution focused on attaining the most leading and ambitious scopes in the fields of cell therapy in the UAE. Serving concurrently as Adjunct Professor at United Arab Emirates University, Prof. Dr. Ventura is a skilled leader and scientific researcher in preforming, conducting, and analyzing in vivo and in vitro assays. His clinical experience revolves around clinical research and preclinical studies related to cell biology, immunology, cancer, and autoimmune diseases.
Prof. Dr. Ventura has developed UAECell-19©, a new innovative methodology for harvesting stem cells through peripheral blood which was used in a clinical trial for COVID-19 patients, with ADSCC as its sole owner. He also established the first bone marrow transplantation program in the UAE, known as AD-BMT©, with intellectual property rights. He has also led the implementation of the UAE’s very first CAR-T cells and Extracorporeal Photopheresis program. Prof. Dr. Ventura is also the Chairman of the Pharmacogenomics Flagship Program of ADSCC and the Principal Investigator of randomized controlled clinical trials for Multiple Sclerosis, Type 1 Diabetes Mellitus, and others.
He brings a wealth of leadership and clinical expertise, including performance in clinical sciences, managing clinical research and leading clinical trials. He has extensive knowledge in stem cell harvesting and isolation, using these techniques in the implementation of therapeutic and productive apheresis methods used in hematopoietic stem cells transplantations, as well as obtaining autologous stem cells for regenerative medicine. Prof. Dr. Yendry’s primary field of interest is in preclinical and clinical research such as clinical trials and compassionate protocols.
Prof. Dr. Ventura holds a Doctorate in Medicine in Immunology from the University of Havana- Cuba and he is currently pursuing his Master’s degree in Healthcare Management from Johns Hopkins University in the US.